197 related articles for article (PubMed ID: 25410862)
21. Analysis of specificity determinants in the interactions of different HPV E6 proteins with their PDZ domain-containing substrates.
Thomas M; Dasgupta J; Zhang Y; Chen X; Banks L
Virology; 2008 Jul; 376(2):371-8. PubMed ID: 18452965
[TBL] [Abstract][Full Text] [Related]
22. [Possible role of transcription factor AP1 in the tissue-specific regulation of human papillomavirus].
Velazquez Torres A; Gariglio Vidal P
Rev Invest Clin; 2002; 54(3):231-42. PubMed ID: 12183893
[TBL] [Abstract][Full Text] [Related]
23. Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways.
Ganti K; Massimi P; Manzo-Merino J; Tomaić V; Pim D; Playford MP; Lizano M; Roberts S; Kranjec C; Doorbar J; Banks L
PLoS Pathog; 2016 Sep; 12(9):e1005854. PubMed ID: 27649450
[TBL] [Abstract][Full Text] [Related]
24. Structural analysis of human papillomavirus E6 interactions with Scribble PDZ domains.
Stewart BZ; Caria S; Humbert PO; Kvansakul M
FEBS J; 2023 Jun; 290(11):2868-2880. PubMed ID: 36609831
[TBL] [Abstract][Full Text] [Related]
25. Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins.
Pim D; Thomas M; Banks L
Oncogene; 2002 Nov; 21(53):8140-8. PubMed ID: 12444549
[TBL] [Abstract][Full Text] [Related]
26. The biology of papillomavirus PDZ associations: what do they offer papillomaviruses?
Thomas M; Banks L
Curr Opin Virol; 2021 Dec; 51():119-126. PubMed ID: 34655911
[TBL] [Abstract][Full Text] [Related]
27. Structural and functional characterization of the PDZ domain of the human phosphatase PTPN3 and its interaction with the human papillomavirus E6 oncoprotein.
Genera M; Samson D; Raynal B; Haouz A; Baron B; Simenel C; Guerois R; Wolff N; Caillet-Saguy C
Sci Rep; 2019 May; 9(1):7438. PubMed ID: 31092861
[TBL] [Abstract][Full Text] [Related]
28. The PDZ domain binding motif (PBM) of human T-cell leukemia virus type 1 Tax can be substituted by heterologous PBMs from viral oncoproteins during T-cell transformation.
Aoyagi T; Takahashi M; Higuchi M; Oie M; Tanaka Y; Kiyono T; Aoyagi Y; Fujii M
Virus Genes; 2010 Apr; 40(2):193-9. PubMed ID: 20069350
[TBL] [Abstract][Full Text] [Related]
29. Structural insights into a wildtype domain of the oncoprotein E6 and its interaction with a PDZ domain.
Mischo A; Ohlenschläger O; Hortschansky P; Ramachandran R; Görlach M
PLoS One; 2013; 8(4):e62584. PubMed ID: 23638119
[TBL] [Abstract][Full Text] [Related]
30. Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators.
Tomaić V; Gardiol D; Massimi P; Ozbun M; Myers M; Banks L
Oncogene; 2009 Jan; 28(1):1-8. PubMed ID: 18820705
[TBL] [Abstract][Full Text] [Related]
31. Design of a PDZbody, a bivalent binder of the E6 protein from human papillomavirus.
Karlsson OA; Ramirez J; Öberg D; Malmqvist T; Engström Å; Friberg M; Chi CN; Widersten M; Travé G; Nilsson MT; Jemth P
Sci Rep; 2015 Mar; 5():9382. PubMed ID: 25797137
[TBL] [Abstract][Full Text] [Related]
32. Regulation of the Wnt/β-Catenin Signaling Pathway by Human Papillomavirus E6 and E7 Oncoproteins.
Bello JO; Nieva LO; Paredes AC; Gonzalez AM; Zavaleta LR; Lizano M
Viruses; 2015 Aug; 7(8):4734-55. PubMed ID: 26295406
[TBL] [Abstract][Full Text] [Related]
33. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31.
Lee C; Laimins LA
J Virol; 2004 Nov; 78(22):12366-77. PubMed ID: 15507623
[TBL] [Abstract][Full Text] [Related]
34. An internal class III PDZ binding motif in HPV16 E6* protein is required for Dlg degradation activity.
Umnajvijit W; Sangthong J; Loison F; Vaeteewoottacharn K; Ponglikitmongkol M
Biochim Biophys Acta Gen Subj; 2021 May; 1865(5):129850. PubMed ID: 33486056
[TBL] [Abstract][Full Text] [Related]
35. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo.
Nguyen ML; Nguyen MM; Lee D; Griep AE; Lambert PF
J Virol; 2003 Jun; 77(12):6957-64. PubMed ID: 12768014
[TBL] [Abstract][Full Text] [Related]
36. Human papillomavirus oncoproteins.
Vousden KH
Semin Cancer Biol; 1990 Dec; 1(6):415-24. PubMed ID: 1966493
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of the hDlg/SAP97 PDZ2 domain and its mechanism of interaction with HPV-18 papillomavirus E6 protein.
Liu Y; Henry GD; Hegde RS; Baleja JD
Biochemistry; 2007 Sep; 46(38):10864-74. PubMed ID: 17713926
[TBL] [Abstract][Full Text] [Related]
38. HPV E6 oncoprotein as a potential therapeutic target in HPV related cancers.
Manzo-Merino J; Thomas M; Fuentes-Gonzalez AM; Lizano M; Banks L
Expert Opin Ther Targets; 2013 Nov; 17(11):1357-68. PubMed ID: 24094136
[TBL] [Abstract][Full Text] [Related]
39. Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses.
Javier RT; Rice AP
J Virol; 2011 Nov; 85(22):11544-56. PubMed ID: 21775458
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle.
Lee C; Wooldridge TR; Laimins LA
Virology; 2007 Feb; 358(1):201-10. PubMed ID: 16999984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
